AZN STOCK ANALYSIS
Price summary
Last Close
14,456.00 $
Jul 3, 26
Market Cap
301 B $
Q1 2026 (TTM)
52-Week Range
Return and risk cards
Total Return
%+44.1
Volatility
%25.3
Sharpe Ratio
-0.02
Sortino Ratio
-0.02
Distance to Peak
%-7.0
Maximum Drawdown
-%15.4
Seasonality
Seasonality Chart
Periodic Returns
1M
+9.4%
3M
-5.6%
6M
+7.5%
YTD
+5.9%
1Y
+44.1%
3Y
+45.1%
Returns are computed from split-adjusted closes; dividends are not included.
YTD Return — Stock vs Asset Classes
Year-to-dateStock and gold/silver returns are in USD (metals converted into the stock's currency). The FTSE 100 index is measured in its own currency.
Monthly positivity
Monthly Avg Positive/Negative Close
Frequently Asked Questions
What is the current AstraZeneca PLC (AZN) stock price?
AZN last closed at 14,456.00 $ (Jul 3, 26). Price data is refreshed after every trading day.
What is the P/E ratio of AZN?
AstraZeneca PLC trades at a trailing-twelve-month P/E of 28.79. See the comparison tables on the Peers tab for the industry context.
What is the market capitalization of AstraZeneca PLC?
AstraZeneca PLC (AZN) has a market capitalization of approximately 301 B $ as of the latest reported period.
Who are the main competitors of AZN?
Key peers of AstraZeneca PLC include Organon & Co, Grifols S.A., AstraZeneca PLC, Biogen Inc, Bayer AG NA. A detailed metric comparison is available on the Peers tab.
Go deeper on AZN
Data on this page refreshes once per day. Price data as of Jul 3, 26. This content is for informational purposes only and is not investment advice.
